 |
| Identifying strategies for measuring thousands of microbial and host proteins and revealing what microbes are doing and how the host responds Image Credit: Scientific Frontline / stock image |
Scientific Frontline: Extended "At a Glance" Summary: Metaproteomics in Microbiome Research
The Core Concept: Metaproteomics is the comprehensive study of the entire protein complement produced by complex microbial communities and their hosts, revealing the active physiological functions and interactions within ecosystems like the gut microbiome.
Key Distinction/Mechanism: While modern DNA sequencing identifies the presence of specific microorganisms and their potential capabilities, metaproteomics utilizes advanced mass spectrometry to measure the actual proteins being produced. This mechanism determines exactly which microbial functions are actively occurring and how the host organism is responding in real time.
Major Frameworks/Components:
- Systematic comparison of five state-of-the-art mass spectrometry acquisition strategies (including PASEF) to analyze complex human fecal samples.
- Simultaneous, large-scale measurement of thousands of microbial and host proteins across enormous concentration ranges.
- Monitoring of coordinated host and microbial responses during the onset, progression, and recovery of intestinal inflammation.
- Integration of advanced laboratory automation, mass spectrometry, and artificial intelligence-based data analysis to manage sample complexity.
Branch of Science: Metaproteomics, Microbiology, Systems Biology, Analytical Chemistry, Pharmacology, and Toxicology.
Future Application: These highly sensitive and reproducible analytical strategies will translate into robust clinical applications, facilitating the direct study of the microbiome's involvement in neurological, metabolic, and autoimmune diseases, alongside advancements in environmental science and biotechnology.
Why It Matters: By establishing precise analytical methods, researchers can move beyond simply cataloging microorganisms to actively interpreting their functional roles. This provides vital insights into how microbial activity directly influences human health, disease progression, and the host's biological repair responses.
The trillions of microorganisms living in our intestines influence our health, from digestion and metabolism to immunity. Yet scientists still struggle to understand how these microbes shape these important physiological functions because gut microbiomes are extraordinarily complex, redundant, and dynamic. New technologies are therefore essential for advancing microbiome research. Researchers at the University of Vienna have reported effective strategies for simultaneously measuring thousands of microbial and host proteins. The findings have been published in Nature Communications.
Improving Future Microbiome Research
Microorganisms are essential to the health of ecosystems across the planet, including the human body. Modern DNA sequencing has transformed microbiome research by revealing which microorganisms are present and which functions they could potentially perform. This is similar to identifying the musicians in an orchestra and the pieces they can play. However, DNA alone cannot tell us which piece is actually being performed.
Proteins provide this missing information. They reveal which microbial functions are active, how different microbiome members contribute, and, importantly, how the host responds. In the orchestra analogy, proteins show not only which musicians are present but also which piece they are playing and how the audience—the host—reacts.
In the new study, the researchers systematically compared five state-of-the-art mass spectrometry approaches using human fecal samples. Ultimately, they identified methodological strategies that provide high sensitivity, reproducibility, and functional insight. For this study, researchers from the Bruker Daltonics Center of Excellence (CoE) for Metaproteomics and the Systems Biology of Pain Laboratory (Division of Pharmacology and Toxicology) at the University of Vienna worked together.
"Metaproteomics allows us to see what microbial communities are actually doing, rather than simply which microbes are present," says Feng Xian, the first author of the study. "By identifying the most suitable analytical strategies, we hope to make future microbiome research more sensitive, reproducible, and accessible across medicine, environmental science, and biotechnology."
From Technical Developments to Clinical Insights
The researchers tested whether the new analytical strategies also perform robustly in a biologically relevant setting. They measured microbial and host proteins throughout disease progression and recovery, revealing coordinated changes in microbial functions alongside the host repair response. The best-performing methods captured highly concordant host and microbial responses during the onset and recovery of intestinal inflammation, showing that technological improvements can translate into robust biological insights.
"Developing better technologies is essential if we want to answer the next generation of questions in microbiome research," says David Gomez-Varela, director of the CoE. "Only by listening to the music script played by microbes can we begin to understand why the audience—the host—responds in a particular way. This will transform our understanding of the microbiome's role in human health. We are already applying these advances in international clinical collaborations to study the involvement of microbiomes in neurological, metabolic, and autoimmune diseases."
Reference material: Human Microbiome
About Metaproteomics: The field of metaproteomics is uniquely suited to simultaneously measure thousands of proteins—from microbes and their host. However, gut microbiomes are among the most complex biological samples known, containing proteins from hundreds of organisms across an enormous concentration range. Since its establishment in 2024, the CoE for Metaproteomics at the University of Vienna has been developing new technologies—from laboratory automation and advanced mass spectrometry to AI-based data analysis—to overcome these analytical challenges.
Published in journal: Nature Communications
Title: Systematic evaluation of PASEF acquisition strategies in complex metaproteomes
Authors: Feng Xian, Goran Mitulovic, Ranjith Kumar Ravi Kumar, Lukas Uhrik, Elisabeth Urbauer, Doriane Aguanno, Dirk Haller, Manuela Schmidt, and David Gomez-Varela
Source/Credit: Universität Wien
Edited by: Scientific Frontline
Reference Number: mcb080326_01
